Keywords: dti, grant, mnlpharma, sugar, adjuvant, technology, uk

DTI grant for MNLpharma's sugar adjuvant technology

Article | 27 March 2006

Print This

UK drug discovery firm MNLpharma says that, in conjunction with Cambridge BioStability and the University of Cambridge, it has received ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in